"Helper Viruses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Viruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective (satellite) virus. Helper and satellite may be of the same or different genus.
Descriptor ID |
D006378
|
MeSH Number(s) |
B04.423
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Helper Viruses".
Below are MeSH descriptors whose meaning is more specific than "Helper Viruses".
This graph shows the total number of publications written about "Helper Viruses" by people in this website by year, and whether "Helper Viruses" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 2 | 2 |
2001 | 1 | 1 | 2 |
2002 | 2 | 0 | 2 |
2003 | 1 | 1 | 2 |
2004 | 0 | 3 | 3 |
2005 | 4 | 0 | 4 |
2006 | 3 | 1 | 4 |
2007 | 1 | 1 | 2 |
2008 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 0 | 2 | 2 |
2012 | 0 | 1 | 1 |
2013 | 1 | 2 | 3 |
2016 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Helper Viruses" by people in Profiles.
-
Adeno-associated virus type 2 in US children with acute severe hepatitis. Nature. 2023 May; 617(7961):574-580.
-
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820.
-
Long-term, high-level hepatic secretion of acid a-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus. Gene Ther. 2016 10; 23(10):743-752.
-
Improved efficacy and reduced toxicity by ultrasound-guided intrahepatic injections of helper-dependent adenoviral vector in Gunn rats. Hum Gene Ther Methods. 2013 Oct; 24(5):321-7.
-
Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors. Hum Gene Ther. 2013 Aug; 24(8):761-5.
-
Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One. 2013; 8(7):e67574.
-
Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo. Mol Ther. 2013 Apr; 21(4):796-805.
-
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques. Mol Ther. 2012 Oct; 20(10):1863-70.
-
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. Hum Gene Ther. 2011 Sep; 22(9):1071-82.
-
Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges. Curr Pharm Des. 2011; 17(24):2488-99.